• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS RUBELLA IGG IMMUNOASSAY; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS RUBELLA IGG IMMUNOASSAY; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA Back to Search Results
Catalog Number 04618793160
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/06/2021
Event Type  malfunction  
Manufacturer Narrative
The patient sample from (b)(6) 2021 (sample 3) was sent for investigation and was tested on a cobas e602 with retention kits.The elecsys rubella igg immunoassay investigation result was 21.23 iu/ml, a positive result; the elecsys rubella igm immunoassay investigation result was 0.272 coi (non-reactive).The investigation is ongoing.
 
Event Description
There was a complaint of discrepant elecsys rubella igg immunoassay (igg) results for 1 patient tested with a cobas 8000 e602 module.The discrepant results were not reported outside the laboratory.The patient¿s sample 1 initial igg result in july 2021 was 6.66 ui/ml and the sample received an elecsys rubella igm immunoassay (igm) result of 0.2 coi.Both initial igg and igm results were negative.The patient's sample 2 was run twice on (b)(6) 2021.The first igg result was 13.08 ui/ml and the sample received an igm result of 0.2 coi.The repeat igg result was 12.59 ui/ml on (b)(6) 2021.Both igg results were positive while the igm result was negative.The patient¿s sample 3 was run on (b)(6) 2021 with an igg result of 21.67 ui/ml and an igm result of 0.2 coi; and repeated on a diasorin analyzer where it got negative results for both igg and igm.The cobas results were positive for igg and negative for igm.The patient had a rubella igg result of 20.93 ui/ml on (b)(6) 2021.It is unknown if the patient is vaccinated for rubella.
 
Manufacturer Narrative
The calibration from 06-aug-2021 met acceptance criteria.The qc from 03-sep-2021 met acceptance criteria.No qc data was provided for 19-jul- and 06-aug-2021.The investigation found no issues with the reagent.The investigation found the customer¿s positive result for elecsys rubella igg was reproducible with a value of ~21 iu/ml.The investigation tested the patient's sample with the mikrogen recomblot, platelia rubella igg, and a neutralization experiment.All results supported the positive elecsys rubella igg result.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS RUBELLA IGG IMMUNOASSAY
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key12546663
MDR Text Key273781966
Report Number1823260-2021-02849
Device Sequence Number1
Product Code LFX
UDI-Device Identifier04015630939251
UDI-Public04015630939251
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K072617
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2022
Device Catalogue Number04618793160
Device Lot Number53329902
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/03/2021
Initial Date FDA Received09/29/2021
Supplement Dates Manufacturer Received11/10/2021
Supplement Dates FDA Received11/29/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age18 YR
Patient SexFemale
-
-